Quest Diagnostics (DGX) Enterprise Value (2009 - 2026)

Quest Diagnostics has disclosed Enterprise Value across 18 years of filings, most recently posting $23.1 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 16.23% year-over-year to $23.1 billion; the TTM figure through Jun 2026 stood at $23.1 billion (up 16.23% YoY), while the FY2025 annual figure was $18.7 billion, up 15.05% from the prior year.
• Enterprise Value came in at $23.1 billion for Q2 2026 at Quest Diagnostics, up from $21.6 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $23.1 billion in Q2 2026 to a low of $13.3 billion in Q3 2022.
• Average Enterprise Value over 5 years is $17.0 billion, with a median of $16.0 billion recorded in 2023.
• Year-over-year, Enterprise Value fell 21.09% in 2022 and soared 31.93% in 2025.
• Over 5 years, Enterprise Value stood at $17.2 billion in 2022, then retreated by 14.69% to $14.7 billion in 2023, then grew by 11.07% to $16.3 billion in 2024, then increased by 15.05% to $18.7 billion in 2025, then climbed by 23.21% to $23.1 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $23.1 billion in Q2 2026, $21.6 billion in Q1 2026, and $18.7 billion in Q4 2025.